BCRX Next Earnings Date Notes

— BioCryst Pharmaceuticals, Inc. (BCRX) is a commercial-stage biotech company focused on developing & commercializing novel small molecule drugs for rare diseases. Its lead product, ORLADEYO—an oral, once-daily treatment for hereditary angioedema (HAE)—drives its revenues and growth potential. Investors should pay close attention to ORLADEYO sales momentum, especially quarterly net product revenues, as this metric directly reflects patient uptake and market penetration. Key operational milestones, such as regulatory submissions/approvals for additional indications & geographies, are also highly relevant. For long-term success, keep an eye on the overall pipeline (including BCX10013 for complement-mediated diseases) and R&D progress updates. Monitoring the company’s cash position, expense trends, and pathway to profitability is critical, given the capital requirements of biotech commercialization. On earnings calls, management commentary about patient growth, payer dynamics, inventory levels, and international launch updates will help gauge the sustainability of current growth and provide a lens on future catalysts. Understanding these metrics will provide a solid foundation for evaluating BCRX’s evolving business trajectory. The next projected earnings date for BCRX is 8/3/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

BioCryst Pharma Next Earnings Date FAQ

On this page we presented the BioCryst Pharma Next Earnings Date information for BioCryst Pharma along with recent past earnings dates. For Q1 of 2026, BCRX reported earnings of 0.140/share, with the earnings report taking place on 5/6/2026. For Q4 of 2025, BCRX reported earnings of 0.055/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, BCRX reported earnings of 0.160/share, with the earnings report taking place on 11/3/2025. For Q2 of 2025, BCRX reported earnings of 0.150/share, with the earnings report taking place on 8/4/2025. For Q1 of 2025, BCRX reported earnings of 0.000/share, with the earnings report taking place on 5/5/2025. Based on these past earnings dates, the projected next earnings date for BCRX is 8/3/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as BioCryst Pharma. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to BioCryst Pharma shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research BioCryst Pharma next earnings dates as well as any other stock out there in our coverage universe, to see when the next BCRX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up BCRX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the BCRX next earnings date.